Warfarin potassium, 3-( -acetonylbenzyl)-4-hydroxycoumarin potassium salt(Athrombin-K), is readily absorbed after oral administration,and a therapeutic hypoprothrombinemia is produced within12 to 24 hours after administration of 40 to 60 mg. This saltis therapeutically interchangeable with warfarin sodium.
